Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India

Satchit Balsari; Zarir Udwadia; Ahmed Shaikh; Abdul Ghafur; Sushila Kataria

doi:10.1016/S1473-3099(21)00329-7

Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India

Satchit Balsari
, Zarir Udwadia
, Ahmed Shaikh
, Abdul Ghafur
, Sushila Kataria

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Original language	English
Pages (from-to)	905-907
Number of pages	3
Journal	The Lancet Infectious Diseases
Volume	21
Issue number	7
DOIs	https://doi.org/10.1016/S1473-3099(21)00329-7
State	Published - Jul 2021
Externally published	Yes

Access to Document

10.1016/S1473-3099(21)00329-7

Cite this

@article{f597fb739e21482b8d6683c63ae23544,

title = "Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India",

author = "Satchit Balsari and Zarir Udwadia and Ahmed Shaikh and Abdul Ghafur and Sushila Kataria",

note = "Funding Information: ZU serves on the Maharashtra Covid Task Force and National Task Force constituted by the Supreme Court of India; and has received honoraria or grants from AstraZeneca and Glenmark. AG has received grants from Cipla, Glenmark, Pfizer, Sanofi, Astellas, Mylan, Natco, Biomerioux, Bharath Serum, and GlaxoSmithKline. All other authors declare no competing interests.",

year = "2021",

month = jul,

doi = "10.1016/S1473-3099(21)00329-7",

language = "English",

volume = "21",

pages = "905--907",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India

AU - Balsari, Satchit

AU - Udwadia, Zarir

AU - Shaikh, Ahmed

AU - Ghafur, Abdul

AU - Kataria, Sushila

N1 - Funding Information: ZU serves on the Maharashtra Covid Task Force and National Task Force constituted by the Supreme Court of India; and has received honoraria or grants from AstraZeneca and Glenmark. AG has received grants from Cipla, Glenmark, Pfizer, Sanofi, Astellas, Mylan, Natco, Biomerioux, Bharath Serum, and GlaxoSmithKline. All other authors declare no competing interests.

PY - 2021/7

Y1 - 2021/7

UR - https://www.scopus.com/pages/publications/85108433623

U2 - 10.1016/S1473-3099(21)00329-7

DO - 10.1016/S1473-3099(21)00329-7

M3 - Comment/debate

C2 - 34115966

AN - SCOPUS:85108433623

SN - 1473-3099

VL - 21

SP - 905

EP - 907

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 7

ER -